BMS to pump $300m into India with new R&D deals
Bristol-Myers Squibb (BMS) has this week inked two large R&D services contracts in India as it dips its toe further into this budding region.
Bristol-Myers Squibb (BMS) has this week inked two large R&D services contracts in India as it dips its toe further into this budding region.
A potential new law mandating the running of clinical trials before a "generic" biologic drug approval may seem like a potential goldmine for contract research organisations (CROs), however, this vision is premature.
In-PharmaTechnologist.com and Outsourcing-Pharma.com journalist Kirsty Barnes has received the honour of being announced among the place winners of the 2006 Awards for Excellence in Health Care Journalism (AHCJ).
In the latest of a rash of pharmaceutical plant closures, Sanofi-Aventis has announced proposals to cease operations at its Waterford, Ireland site.